Recent Financing
Recent Raise
BrainChild Bio is a clinical-stage biotechnology company developing CAR T cell therapies targeting tumors in the central nervous system.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at BrainChild Bio.